Registration Process of Generic Budesonide DPI as per USFDA Guidelines
Hansal Gandhi
Broschiertes Buch

Registration Process of Generic Budesonide DPI as per USFDA Guidelines

Dossier Submission of Budesonide Dry Powder Inhaler with the application of eCTD Software

Versandkostenfrei!
Versandfertig in 6-10 Tagen
40,99 €
inkl. MwSt.
PAYBACK Punkte
20 °P sammeln!
The purpose of this book is to develop a hypothetical dossier based on regulations and guidances which are required to be followed when an actual submission is filed to the USFDA, with an objective to meet the Common Technical Document(CTD) requirements. For this purpose, Budesonide Dry Powder Inhaler(DPI) is selected as a product to prepare a hypothetical dossier. In terms of volume by 2026 it is expected that requirement of DPI in USA would be increased and may reach up to 400 million units per year due to increasing air pollution and increased rate of respiratory diseases in children as wel...